A 32-year-old Woman with Right-Sided Numbness and Word-Finding Difficulties
Neurol 83:e98-e102, Busza, A.,et al, 2014
Clinicopathologic Conference, Streptococcus Bovis Associated Meningitis and the Strongyloides Stercoralis Hypertension Syndrome
NEJM 371:1051-1060, Case 28-2014, 2014
Hormone Replacement Therapy and Adverse Outcomes in Women with Atrial Fibrillation
Stroke 45:3076-3079, Apostolakis, S.,et al, 2014
Preadmission Oral Anticoagulant Treatment and Clinical Outcome Among Patients Hospitalized with Acute Stroke and Atrial Fibrillation
Stroke 45:168-175, Johnsen, S.P.,et al, 2014
Detection of Atrial Fibrillation After Ischemic Stroke or Transient Ischemic Attack
Stroke 45:520-526,355, Kishore, A.,et al, 2014
Clinicopathologic Conference, Infective Endocarditis and Infectious Aortitis due to Staphylococcus Aureus
NEJM 370:651-660, Case 5-2014, 2014
Summary of Evidence-Based Guideline Update: Prevention of Stroke in Nonvalvular Atrial Fibrillation
Neurol 82:716-724, Culebras, A.,et al, 2014
Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial
Neurol 82:744-751, Marshall, R.S.,et al, 2014
The Safety of Aeroplane Travel in Patients with Symptomatic Carotid Occlusion
JNNP 85:435-437, Reynolds, M.R.,et al, 2014
Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in Patients with Atrial Fibrillation: A Meta-Analysis of Randomised Trials
Lancet 383:955-962,931, Ruff, C.T.,et al, 2014
Prolonged Cardiac Monitoring for Detection of Paroxysmal Atrial Fibrillation After Cerebral Ischemia
Stroke 45:1208-1214, Rabinstein, A.A., 2014
Rethinking Warfarin for Atrial Fibrillation
JAMA 311:1246, Zuccott, G & Pflomm, J.M., 2014
Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients with Atrial Fibrillation
JAMA 311:1150-1151, Bruins Slot, K.M.H. & Berge, E., 2014
Degenerative Diseases of the Nervous System, Friedreich Ataxia
Adams & Victors Principles of Neurology, Chp 39, pg 1102, Ropper, A.H.,et al, 2014
Recognition and Management of Withdrawal Delirium
NEJM 371:2109-2113, Schuckit, M.A., 2014
Oral Anticoagulants and the Risk of Intracranial Hemorrhage
JAMA 312:2562-2563, Vespa, P.M., 2014
Association of Cerebral Microbleeds with Mortality in Stroke Patients Having Atrial Fibrillation
Neurol 83:1308-1315,1304, Song, T.J.,et al, 2014
Occult Atrial Fibrillation in Cryptogenic Stroke
Stroke 44:1449-1452, Ritter, M.,et al, 2013
Incidence of Atrial Fibrillation Detected by Implantable Loop Recorders in Unexplained Stroke
Neurol 80:1546-1550, Corter, P.,et al, 2013
Comatose Patient with Bilateral Thalamic Infarct due to Internal Carotid Artery Occlusion
Neurol 80:e185-186, Dababneh, H.,et al, 2013
Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
Stroke 44:1676-1681, Harringotn, A.,et al, 2013
Summary of Evidence-Based Guideline: Periprocedural Management of Antithrombic Medications in Patients with Ischemic Cerebrovascular Disease
Neurol 80:2065-2069, Armstrong, M.,et al, 2013
Pilot Randomized Trial of Outpatient Cardiac Monitoring After Cryptogenic Stroke
Stroke 44:528-530, Kamel, H.,et al, 2013
Diffusion-Weighted Magnetic Resonance Imaging May Underestimate Acute Ischemic Lesions
Stroke 44:1056-1061, Kawana, H.,et al, 2013
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013
Newly Diagnosed Atrial Fibrillation Linked to Wake-Up Stroke and TIA
Neurol 80:1834-1840, Riccio, P.,et al, 2013
Insertable Cardiac Event Recorder in Detection of Atrial Fibrillation After Cryptogenic Stroke
Stroke 44:2007-2009, Etgen, T.,et al, 2013
Clinicopathologic Conference, Oligoastrocytoma, Grade II with Temporal-Lobe Seizure and Ictal Asystole (Arrhythmogenic Epilepsy)
NEJM 368:2304-2312, Case 18-2013, 2013
An Index to Identify Stroke-Related vs Incidental Patent Foramen Ovale in Cryptogenic Stroke
Neurol 81:619-625,619, Kent, D.M.,et al, 2013
Patent Foramen Ovale and Cryptogenic Stroke
Stroke 44:2676-2678, Furlan, A.J. and Jauss, M., 2013
Faxtor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients with Atrial Fibrillation
Stroke 44:e165-e167, Bruins, K.M.H., & Berge, E., 2013
Spectrum of Transient Visual Symptoms in a Transient Ischemic Attack Cohort
Stroke 44:3312-3317, Lavallee, P.C.,et al, 2013
Evaluation of Patients for Paroxysmal Atrial Fibrillation after Ischemic Stroke
Stroke 44:e168-e170, Sundararajan, K.,et al, 2013
Edoxaban Versus Warfarin in Patients with Atrial Fibrillation
NEJM 369:2093-2104, Giugliano, R.P.,et al, 2013
Stroke Patients with Suspected Atrial Fibrillation Should be Started on Anticoagulation Pending the Results of Long-Term Cardiac Monitoring
Stroke 44:298-299,302, Diener, H., 2013
Stroke Patients with Suspected Atrial Fibrillation Should NOT be Started on Anticoagulation WHILE AWAITING the Results of Long-Term Cardiac Monitoring
Stroke 44:300-301,302, Katsnelson, M. & Sacco, R., 2013
Left Atrial Catheter Ablation and Ischemic Stroke
Stroke 43:265-270, Haeusler, K.G.,et al, 2012
Using Dabigatran in Patients with Stroke A Practical Guide for Clinicians
Stroke 43:271-279, Alberts, M.J.,et al, 2012
Subclinical Atrial Fibrillation and the Risk of Stroke
NEJM 366:120-129,178, Healey, J.S., et al, 2012
Management of Anticoagulation Before and After Elective Surgery
www.uptodate.com Dec. 2012, Lip, G. & Douketis, J., 2012
Spontaneous Primary Intraventricular Hemorrhage: Clinical Features and Early Outcome
ISRN Neurology ED498303, Arboix, A.,et al, 2012
Neurological Complications of Sclerotherapy for Varicose Veins
J Vasc Surg 55:243-251, Sarvananthan, T.,et al, 2012
New Antithrombotic Drugs for Atrial Fibrillation: Caution is Needed
Lancet 379:e24, Bell,S.,et al, 2012
Self-Monitoring of Oral Anticoagulation: Systematic Review and Meta-Analysis of Individual Patient Data
Lancet 379:322-34, Heneghan,C., 2012
Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention
Stroke 43:422-431, Kitsios,G.D.,et al, 2012
Anticoagulant Loses its Lustre
Lancet 379:301, Mullar,A., 2012
Cost-Effectiveness of Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Stroke 43:881-883, Kamel,H.,et al, 2012
Critique of Apixaban Versus Warfarin in Patients with Atrial Fibrillation
Stroke 43:922-923, Nedeltchev,K, 2012
Syncope: A Rare Manifestation of a Common Condition
Lancet 379:866, Hogarth,A.,et al, 2012